Attached files

file filename
S-1/A - S-1/A - INTERMOLECULAR INCa2206028zs-1a.htm
EX-3.4 - EX-3.4 - INTERMOLECULAR INCa2206424zex-3_4.htm
EX-5.1 - EX-5.1 - INTERMOLECULAR INCa2206424zex-5_1.htm
EX-3.1 - EX-3.1 - INTERMOLECULAR INCa2206424zex-3_1.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1


Consent of Independent Registered Public Accounting Firm

The Board of Directors
Intermolecular, Inc.:

        We consent to the use of our report dated June 30, 2011, except as related to note 6(a) to the consolidated financial statements which is as of July 28, 2011 and the "Stock Split" section of note 1 which is as of November 15, 2011, included herein and to the reference to our firm under the heading "Experts" in the prospectus. Our report refers to the change in the manner in which the Company accounted for convertible preferred stock.

/s/ KPMG LLP

Mountain View, California
November 15, 2011




QuickLinks

Consent of Independent Registered Public Accounting Firm